Digital Humans in Extremes: Insights from Frontiers Health 2025 pharmaphorum chatted with Jack Kreindler (WellFounded) after his onstage session at Frontiers Health 2025.
News Jazz builds in epilepsy with $1.3bn Actio acquisition Jazz Pharma has dipped its toe into the M&A water again, agreeing to buy rare epilepsy drug developer Actio Bio for $820m upfront.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
